Royal Jelly acid

CAS No. 14113-05-4

Royal Jelly acid( —— )

Catalog No. M18005 CAS No. 14113-05-4

10-Hydroxy-2-decenoic acid is an inhibitor of VEGF-induced angiogenesis, cell migration and proliferation.

10-Hydroxy-2-decenoic acid is an inhibitor of VEGF-induced angiogenesis, cell migration and proliferation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 39 In Stock
100MG 56 In Stock
500MG 133 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Royal Jelly acid
  • Note
    Research use only, not for human use.
  • Brief Description
    10-Hydroxy-2-decenoic acid is an inhibitor of VEGF-induced angiogenesis, cell migration and proliferation.
  • Description
    10-Hydroxy-2-decenoic acid is an inhibitor of VEGF-induced angiogenesis, cell migration and proliferation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    14113-05-4
  • Formula Weight
    186.25
  • Molecular Formula
    C10H18O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (536.91 mM)
  • SMILES
    C(CCC/C=C/C(=O)O)CCCO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yang XH, et al. Comparative proteomic analysis provides insight into 10-hydroxy-2-decenoic acid biosynthesis in honey bee workers. Amino Acids. 2017 Apr 17.
molnova catalog
related products
  • GRL-079

    GRL-079 is a novel potent, nonpeptidic HIV-1 protease inhibitor with 2.5-30 nM.

  • Peptide T

    Peptide T is an octapeptide from the V2 region of HIV-1 gp120. Peptide T is a synthetic octapeptide whose possible mechanism of action is the competitive inhibition of gp120 to the CD4 receptor as well as binding to vasointestinal peptide receptors and inhibiting cytokine action.

  • I-XW-053

    I-XW-053 is an inhibitor of capsid targeted HIV-1 replication using the hybrid structure based method to block the interface between CA N-terminal domains (NTD-NTD interface) with micromolar affinity.